BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2988225)

  • 1. Prospects for improved foot and mouth disease vaccines.
    Doel TR
    Vaccine; 1985 Mar; 3(1):35-6. PubMed ID: 2988225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel approaches to foot and mouth disease vaccination.
    Rowlands DJ
    Vaccine; 1985 Mar; 3(1):37-9. PubMed ID: 2988226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to vaccination against foot-and-mouth disease.
    Brown F
    Vaccine; 1992; 10(14):1022-6. PubMed ID: 1335197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against viral infections with the aid of synthetic peptides. Foot-and-mouth disease as an example.
    Vol'pina OM; Surovoi AYu ; Ivanov VT
    Biomed Sci; 1990 Jan; 1(1):23-32. PubMed ID: 1718462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.
    Doel TR; Gale C; Brooke G; DiMarchi R
    J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in foot-and-mouth disease vaccines.
    Barteling SJ; Vreeswijk J
    Vaccine; 1991 Feb; 9(2):75-88. PubMed ID: 1647575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus.
    Kitching RP; Rendle R; Ferris NP
    Vaccine; 1988 Oct; 6(5):403-8. PubMed ID: 2848376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
    Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
    Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
    Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
    Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of diethylaminoethyl-dextran (DEAE-D) as adjuvant for immunization of guinea pigs with inactivated foot-and-mouth disease (FMD) virus].
    Wittmann G
    Zentralbl Bakteriol Orig; 1970; 213(1):1-8. PubMed ID: 4318268
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthetic peptide vaccines against foot and mouth disease.
    Murdin AD
    Vaccine; 1986 Dec; 4(4):210-1. PubMed ID: 3026104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy testing of anti-foot-and-mouth disease vaccines in guinea pigs using myotropic strains].
    Eissner G; Böhm HO
    Dev Biol Stand; 1976; 35():279-83. PubMed ID: 198295
    [No Abstract]   [Full Text] [Related]  

  • 16. Experiments on an early protection against foot-and-mouth disease virus.
    Liebermann HT; Thalmann G; Bartels T; Nöckler A
    Acta Virol; 1993; 37(2-3):181-3. PubMed ID: 8105663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi R; Little S; Gale C
    Adv Exp Med Biol; 1991; 303():211-20. PubMed ID: 1725233
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain.
    González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F
    Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease--one of the remaining great plagues.
    Brown F
    Proc R Soc Lond B Biol Sci; 1986 Dec; 229(1256):215-26. PubMed ID: 2881301
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission.
    Salt JS; Barnett PV; Dani P; Williams L
    Vaccine; 1998 Apr; 16(7):746-54. PubMed ID: 9562696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.